MCF Advisors’s Idexx Laboratories IDXX Stock Holding History

MCF Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.16K	Buy	+6	New	+$3.37K	﹤0.01%	1228
2026 Q1	–	Sell	-13	Closed	-$8.79K	–	1366
2025 Q4	$8.79K	Buy	13 +8	+160%	+$5.45K	﹤0.01%	858
2025 Q3	$3.19K	Buy	+5	New	+$3.04K	﹤0.01%	850
2025 Q1	–	Sell	-3	Closed	-$1.24K	–	967
2024 Q4	$1.24K	Sell	3 -1	-25%	-$439	﹤0.01%	889
2024 Q3	$2.02K	Hold	4	–	–	﹤0.01%	843
2024 Q2	$1.95K	Hold	4	–	–	﹤0.01%	850
2024 Q1	$2.16K	Buy	4 +1	+33%	+$546	﹤0.01%	813
2023 Q4	$1.67K	Hold	3	–	–	﹤0.01%	797
2023 Q3	$1.31K	Hold	3	–	–	﹤0.01%	805
2023 Q2	$1.51K	Hold	3	–	–	﹤0.01%	742
2023 Q1	$1.5K	Hold	3	–	–	﹤0.01%	739
2022 Q4	$1.22K	Buy	+3	New	+$1.17K	﹤0.01%	726
2022 Q2	–	Sell	-31	Closed	-$17K	–	786
2022 Q1	$17K	Buy	+31	New	+$16.3K	﹤0.01%	474
2021 Q4	–	Sell	-36	Closed	-$22K	–	337
2021 Q3	$22K	Buy	+36	New	+$24.2K	﹤0.01%	402

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

MCF Advisors's IDXX Position: Q2 2026 in Review

MCF Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 6 shares worth $3.16K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings. This is a return to the name: MCF Advisors previously reported a position in IDXX as recently as Q4 2025.

MCF Advisors first reported a position in IDXX in Q3 2021 and has held it in 14 quarters since. The position peaked at $22K in Q3 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

MCF Advisors held 6 shares of Idexx Laboratories worth $3.16K as of Q2 2026.
Idexx Laboratories was a new MCF Advisors position in Q2 2026.
Idexx Laboratories made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1228 holding.
MCF Advisors first reported a position in Idexx Laboratories in Q3 2021 and has held it in 14 quarters since.
MCF Advisors's Idexx Laboratories position peaked at $22K in Q3 2021.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.